EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudieOpen Access · CC BY-NC-ND 4.0

Immune checkpoint inhibitors combined with chemotherapy in conversion therapy for stage IV gastric cancer: a multicenter retrospective cohort study

Xingmao Huang, Xiangliu Chen, Jiahui Chen, Can Hu, Han Chen, Hang Chen, Jingquan Fang, Zeyao Ye, Yian Du, Pengfei Yu, Ling Huang

Cancer Immunology, Immunotherapy · 11.09.2025 · 74 (10)

DOI: 10.1007/s00262-025-04161-6 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Cancer Immunology, Immunotherapy, online erschienen am 11.09.2025. Verfasst von Xingmao Huang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastric Surgery, Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Hangzhou, 310022, Zhejian…. Hauptthemen laut MEDLINE: Stomach Neoplasms, Immune Checkpoint Inhibitors, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsImmune Checkpoint InhibitorsAntineoplastic Combined Chemotherapy ProtocolsHumansFemaleRetrospective StudiesMaleMiddle AgedAgedNeoplasm StagingAdultAged, 80 and over

Stichwörter der Autor:innen

ChemotherapyConversion therapyEfficacyGastric cancerImmune checkpoint inhibitorStage IV

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Gastric Surgery, Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Hangzhou, 310022, Zhejiang, China.
  • Department of Gastrointestinal Surgery, The First Affiliated Hospital of Ningbo University, Ningbo, 315010, Zhejiang, China.
  • Department of Emergency Medicine, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, 31009, Zhejiang, China.
  • Department of Gastric Surgery, Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Hangzhou, 310022, Zhejiang, China. huangling207@163.com.

Förderung

  • Natural Science Foundation of Zhejiang Province

Zitieren

APA

Huang, X., Chen, X., Chen, J., Hu, C., Chen, H., Chen, H., Fang, J., Ye, Z., Du, Y., Yu, P., & Huang, L. (2025). Immune checkpoint inhibitors combined with chemotherapy in conversion therapy for stage IV gastric cancer: a multicenter retrospective cohort study. Cancer Immunology, Immunotherapy, 74(10). https://doi.org/10.1007/s00262-025-04161-6

Vancouver

Huang X, Chen X, Chen J, Hu C, Chen H, Chen H, et al. Immune checkpoint inhibitors combined with chemotherapy in conversion therapy for stage IV gastric cancer: a multicenter retrospective cohort study. Cancer Immunology, Immunotherapy. 2025;74(10). doi:10.1007/s00262-025-04161-6

BibTeX
@article{Huang2025,
  author = {Huang, Xingmao and Chen, Xiangliu and Chen, Jiahui and Hu, Can and Chen, Han and Chen, Hang and Fang, Jingquan and Ye, Zeyao and Du, Yian and Yu, Pengfei and Huang, Ling},
  title = {Immune checkpoint inhibitors combined with chemotherapy in conversion therapy for stage IV gastric cancer: a multicenter retrospective cohort study},
  journal = {Cancer Immunology, Immunotherapy},
  year = {2025},
  volume = {74},
  number = {10},
  doi = {10.1007/s00262-025-04161-6}
}
Kostenlos starten →